|
Volumn 25, Issue 12, 2007, Pages 1331-1332
|
Pfizer dumps Exubera
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATORVASTATIN;
INSULIN;
INSULIN LISPRO;
RECOMBINANT HUMAN INSULIN;
CLINICAL TRIAL;
CONTINUOUS INFUSION;
DIABETES MELLITUS;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG SAFETY;
DRUG UTILIZATION;
HUMAN;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NOTE;
POWDER;
PRIORITY JOURNAL;
PRIVATE PRACTICE;
ADMINISTRATION, INHALATION;
CONSUMER SATISFACTION;
DIABETES MELLITUS;
DRUG INDUSTRY;
HUMANS;
INSULIN;
MARKETING;
NEBULIZERS AND VAPORIZERS;
UNITED STATES;
|
EID: 36849085410
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt1207-1331 Document Type: Note |
Times cited : (54)
|
References (0)
|